Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperpyrexia

M A Denborough

    Comprehensive Therapy
    |December 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Malignant hyperpyrexia, a severe anesthesia complication, is caused by sudden calcium release in muscle cells. Early diagnosis and avoiding triggering anesthetics are crucial for preventing this life-threatening condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dantrolene and "ecstasy".

    The Medical journal of Australia·1997
    Same author

    Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.

    Journal of medical genetics·1995
    Same author

    Molecular cloning of the cDNA encoding human skeletal muscle triadin and its localisation to chromosome 6q22-6q23.

    European journal of biochemistry·1995
    Same author

    The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.

    European journal of biochemistry·1994
    Same author

    Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle.

    Archives of biochemistry and biophysics·1994
    Same author

    Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.

    Biochemical and biophysical research communications·1994
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Problems with computerized health records.

    Comprehensive therapy·2011
    See all related articles

    Area of Science:

    • Anesthesiology
    • Muscle Physiology
    • Genetics

    Background:

    • Malignant hyperpyrexia (MH) is a life-threatening complication of general anesthesia.
    • It occurs in individuals with underlying muscle diseases, characterized by hyperthermia, acidosis, and rigidity.
    • The syndrome results from abnormal calcium ion release in muscle cells upon exposure to anesthetic agents.

    Purpose of the Study:

    • To explain the pathophysiology of malignant hyperpyrexia.
    • To identify predisposing myopathies and diagnostic methods.
    • To outline safe anesthetic practices and treatment strategies for susceptible individuals.

    Main Methods:

    • In vitro studies of human muscle exposed to anesthetic agents.
    • Analysis of experimental data from susceptible pigs.

    Related Experiment Videos

  • Review of clinical features and diagnostic approaches, including serum creatine phosphokinase (CPK) levels and in vitro muscle testing.

    • Main Results:

    • Malignant hyperpyrexia is explained by a massive release of myoplasmic calcium ions.
    • Two predisposing myopathies identified: a subclinical dominant form and a form in boys with physical abnormalities.
    • Serum CPK is a useful but non-specific screening test; in vitro muscle testing is definitive.

    Conclusions:

    • Prophylaxis through early diagnosis and avoidance of triggering anesthetics is paramount.
    • Susceptible individuals can safely receive regional or spinal anesthesia.
    • Alternative anesthetic agents like barbiturates, tranquilizers, and narcotics are considered safe for MH-susceptible patients.